News | TCTAP 2022

Real issue in CABG vs PCI for left main? 'Balancing 'hard' outcomes with patient preferences'

Brian Bergmark, MD addresses real-life implications of meta-analysis that showed no mortality difference between PCI-CABG at TCTAP 2022

News | TCTAP 2022

PCAT attenuation study shows vascular inflammation higher in plaque rupture than plaque erosion

Ik-Kyung Jang, MD presents study findings on pan-coronary inflammation measured by PCAT attenuation at TCTAP 2022

News | TCTAP 2022

From FFR to iFR, QFR to CT-FFR: Experts debate pros and cons of invasive and non-invasive imaging

Heart experts discuss strengths, drawbacks of four major imaging modalities at TCTAP 2022

News | TCTAP 2022

'Understanding interracial disparity may optimize TAVR for AS patients'

Duk-Woo Park, MD examines racial disparities in TAVR procedures and future directions at TCTAP 2022

News | TCTAP 2022

'ISCHEMIA findings bolster argument for invasive revascularization in stable CAD'

Gregg W. Stone, MD emphasizes revasc benefits with PCI, CABG for patients with stable ischemic heart disease at TCTAP 2022

News | TCTAP 2022

Evolution of Asia-Pacific Interventional Cardiology

12th winner of TCTAP’s ‘Master of the Masters’ Award

News | TCTAP 2022

3-tiered risk framework helps improve TAV-in-BAV outcomes, heart expert says

Hasan Jilaihawi, MD stresses systematic use of ‘low-intermediate-high’ TAVR-risk classification for bicuspid aortic valves at TCTAP 2022